Imatinib sensitivity in BCR-ABL1-positive chronic myeloid leukemia cells is regulated by the remaining normal ABL1 allele

Chronic myeloid leukemia in chronic phase (CML-CP) cells that harbor oncogenic BCR-ABL1 and normal ABL1 allele often become resistant to the ABL1 kinase inhibitor imatinib. Here we report that loss of the remaining normal ABL1 allele in these tumors, which results from cryptic interstitial deletion...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Virgili, Anna, Koptyra, Mateusz, Dasgupta, Yashodhara, Glodkowska-Mrowka, Eliza, Stoklosa, Tomasz, Nacheva, Elisabeth P., Skorski, Tomasz
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3156347/
https://ncbi.nlm.nih.gov/pubmed/21693657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-11-0068
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados